SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

SVB Leerink Reiterates Outperform on ChemoCentryx, Raises Price Target to $65

SVB Leerink reiterates ChemoCentryx (NASDAQ:CCXI) with a Outperform and raises the price target from $54 to $65.

Benzinga · 05/12/2020 10:37

SVB Leerink reiterates ChemoCentryx (NASDAQ:CCXI) with a Outperform and raises the price target from $54 to $65.